SEC Form 4 · accession 0001225208-26-006743
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bernard J Zovighian
Officer — CEO · Director
Period of report
Jul 27, 2026
Accepted (ET)
Jul 27, 2026 · 6:59 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2026 | G | 320 | $0.00 | D | 98,845 | D | |
| Common Stock | Jul 27, 2026 | G | 320 | $0.00 | A | 11,836 | I | By Trust |
| Common Stock | Jul 27, 2026 | S | 2,921 | $83.9342 | D | 8,916 | I | By Trust |
| Common Stock | holding | — | — | — | 3,734 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.